Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Recurrence × zimberelimab × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1

Interventions

Cyclophosphamide 5 fludarabine 3 Dasatinib 2 zimberelimab 1 pembrolizumab 1 palbociclib 1 olaparib 1 fluorodopa F 18 1 Vincristine 1 Vemurafenib 1 Topotecan 1 Temozolomide 1 Sirolimus 1 Methotrexate 1 Magnetic Resonance Spectroscopy 1 Influenza Vaccines 1 Fluoxetine 1 Fluorodeoxyglucose F18 1 Everolimus 1 Doxorubicin 1 Decitabine 1 Cholestanetriol 26-Monooxygenase 1 CVAD protocol 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04656535 2026-01-07

AB154 Combined With AB122 for Recurrent Glioblastoma

Yale University

Phase EARLY_PHASE1 Active not recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡